MedTrace Logo

Thermogard™ Efficacy Trial

NCT00822796 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2013-07-24

No results posted yet for this study

Summary

The purpose of this study is to determine if the Thermogard™ central venous catheter can prevent hypothermia (defined as a core body temperature less then 36.0 °C) in severely burned patients who are undergoing surgery for debridement and grafting in the setting of reduced ambient room temperature.

Conditions

  • Hypothermia
  • Burns

Interventions

DEVICE

Thermogard™

Those who have a Thermogard™ central venous warming catheter placed prior to surgery

DEVICE

Standard central venous catheter

Those who have a standard central venous catheter placed prior to surgery

Sponsors & Collaborators

  • Brooke Army Medical Center

    lead FED

Principal Investigators

  • Timothy F. Haley, MD · Brooke Army Medical Center

  • Steven E. Wolf, MD · US Army Institute of Surgical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-10-31
Completion
2009-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00822796 on ClinicalTrials.gov